Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.2.5 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.2.5 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.2.5 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.2.5 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XFORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XFNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
S.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
S.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
S.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
S.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.221.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.221.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.215ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.215ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.215ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.215NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.82ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.82ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.82ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.82NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.462ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.462ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.462ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.462NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.218ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.218ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.218ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.218NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.74ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.74NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.237ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used